GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (BOM:531349) » Definitions » Interest Expense

Panacea Biotec (BOM:531349) Interest Expense : ₹-28 Mil (TTM As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Panacea Biotec Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Panacea Biotec's interest expense for the three months ended in Dec. 2024 was ₹ -10 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₹-28 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Panacea Biotec's Operating Income for the three months ended in Dec. 2024 was ₹ -10 Mil. Panacea Biotec's Interest Expense for the three months ended in Dec. 2024 was ₹ -10 Mil. Panacea Biotec did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Panacea Biotec Interest Expense Historical Data

The historical data trend for Panacea Biotec's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Biotec Interest Expense Chart

Panacea Biotec Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,731.10 -1,846.90 -1,798.37 -38.03 -26.73

Panacea Biotec Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.50 0.87 -8.70 -9.80 -9.90

Panacea Biotec Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panacea Biotec  (BOM:531349) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Panacea Biotec's Interest Expense for the three months ended in Dec. 2024 was ₹-10 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₹-10 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₹0 Mil.

Panacea Biotec's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Panacea Biotec did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Panacea Biotec Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (BOM:531349) » Definitions » Interest Expense
Comparable Companies
BOM:540701 NSE:ZOTA BOM:532067 BOM:543434 BOM:540679 BOM:500259 BOM:524717 BOM:532890 BOM:542910 BOM:511509 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
PANACEABIO:India
Address
Mathura Road, B-1 Extension/G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044
Website
https://www.panaceabiotec.com
Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec Headlines

No Headlines